Monday.com, Zepp Health, and Credo Technology Group Holding Ltd: Analysts Weigh In With Bullish Sentiments
PorAinvest
miércoles, 27 de agosto de 2025, 1:02 am ET1 min de lectura
CRDO--
Monday.com
Monday.com, a leading provider of work management tools, has received a Strong Buy consensus rating from analysts. The stock has an average price target of $266.35, suggesting a 51.5% upside from its current level. Oppenheimer, one of the analysts issuing the report, has set a $300.00 price target on the stock [2]. The company's recent quarterly earnings report showed a strong performance, with revenue increasing by 26.6% year-over-year and earnings per share (EPS) of $1.09, exceeding analyst expectations [1].
Zepp Health
Zepp Health, a company focusing on health and wellness technology, has been given a Moderate Buy consensus rating by analysts. The average price target for Zepp Health is $52.12. The company's recent growth and innovation in the health tech sector have attracted positive analyst sentiment [1].
Credo Technology Group Holding Ltd
Credo Technology Group Holding Ltd has received a Strong Buy consensus rating from analysts, with an average price target of $109.36. This represents a -5.1% downside from the current level. The company's strong market position and growth prospects in the technology sector have contributed to the positive analyst sentiment [1].
Analyst recommendations should be viewed with caution, as they often reflect the vested interests of brokerage firms. It is essential for investors to conduct their own research and consider other indicators, such as the Zacks Rank, which uses earnings estimate revisions to predict stock price movements [1].
ZEPP--
Analysts at Oppenheimer, Mizuho Securities, and Fundamental Research have issued bullish reports on Monday.com, Zepp Health, and Credo Technology Group Holding Ltd, respectively. Monday.com has a Strong Buy consensus rating with an average price target of $266.35, a 51.5% upside from current levels. Zepp Health has a Moderate Buy consensus rating with a $52.12 average price target. Credo Technology Group Holding Ltd has a Strong Buy consensus rating with an average price target of $109.36, representing a -5.1% downside.
Analysts at Oppenheimer, Mizuho Securities, and Fundamental Research have issued bullish reports on Monday.com, Zepp Health, and Credo Technology Group Holding Ltd, respectively. Monday.com has a Strong Buy consensus rating with an average price target of $266.35, a 51.5% upside from current levels. Zepp Health has a Moderate Buy consensus rating with a $52.12 average price target. Credo Technology Group Holding Ltd has a Strong Buy consensus rating with an average price target of $109.36, representing a -5.1% downside.Monday.com
Monday.com, a leading provider of work management tools, has received a Strong Buy consensus rating from analysts. The stock has an average price target of $266.35, suggesting a 51.5% upside from its current level. Oppenheimer, one of the analysts issuing the report, has set a $300.00 price target on the stock [2]. The company's recent quarterly earnings report showed a strong performance, with revenue increasing by 26.6% year-over-year and earnings per share (EPS) of $1.09, exceeding analyst expectations [1].
Zepp Health
Zepp Health, a company focusing on health and wellness technology, has been given a Moderate Buy consensus rating by analysts. The average price target for Zepp Health is $52.12. The company's recent growth and innovation in the health tech sector have attracted positive analyst sentiment [1].
Credo Technology Group Holding Ltd
Credo Technology Group Holding Ltd has received a Strong Buy consensus rating from analysts, with an average price target of $109.36. This represents a -5.1% downside from the current level. The company's strong market position and growth prospects in the technology sector have contributed to the positive analyst sentiment [1].
Analyst recommendations should be viewed with caution, as they often reflect the vested interests of brokerage firms. It is essential for investors to conduct their own research and consider other indicators, such as the Zacks Rank, which uses earnings estimate revisions to predict stock price movements [1].

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios